Latest stories on ELTP
Elite Pharmaceuticals Posts Record Growth Amid Rising Risks
TipRanks58 · neutralearnings
Elite Pharmaceuticals outlines ropinirole launch next month and targets 5% to 10% of its $12M market
Seeking Alpha63 · neutralproduct/pr
Elite Pharmaceuticals, Inc. (ELTP) Q4 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Elite Pharmaceuticals Reports Strong Revenue and Profit Growth
TipRanks67 · bullishearnings
ELITE PHARMACEUTICALS INC /NV/ (ELTP) files 8-K
SEC 8-K50 · neutralgeneral
ELITE PHARMACEUTICALS INC /NV/ (ELTP) files 8-K
SEC 8-K50 · neutralgeneral
Elite Pharmaceuticals Reports Positive Anticonvulsant Bioequivalence Study
TipRanks67 · bullishproduct/pr
ELITE PHARMACEUTICALS INC /NV/ (ELTP) files 8-K
SEC 8-K50 · neutralgeneral
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study | ELTP Stock News
StockTitan67 · bullishproduct/pr
Elite Pharmaceuticals Files ANDA for Blockbuster Anticoagulant Generic
TipRanks63 · neutralproduct/pr